Bone mineral density and bone turnover in asthmatics treated with long-term inhaled or oral glucocorticoids

被引:67
|
作者
Ebeling, PR [1 ]
Erbas, B
Hopper, JL
Wark, JD
Rubinfeld, AR
机构
[1] Royal Melbourne Hosp, Dept Endocrinol & Diabet, Bone & Mineral Serv, Melbourne, Vic 3050, Australia
[2] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Publ Hlth & Community Med, Melbourne, Vic, Australia
[4] Royal Melbourne Hosp, Dept Thorac Med, Melbourne, Vic 3050, Australia
关键词
D O I
10.1359/jbmr.1998.13.8.1283
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inhaled glucocorticoids are pivotal in maintenance therapy of chronic bronchial asthma; however, conflict exists over their effects on bone and mineral metabolism. We measured bone mineral density (BMD), bone turnover markers, and adrenal steroid hormones in 53 patients (34 female, 19 male) with chronic bronchial asthma who had taken either inhaled beclomethasone or budesonide in doses of greater than or equal to 1500 mu g/day for at least 12 months to determine pathogenetic mechanisms of bone loss. To account for the effect of prior oral glucocorticoid exposure we divided patients into two groups: one with (OG) and the other without (IG) a past history of maintenance (> 1 month) oral glucocorticoid therapy. Lumbar spine (LS) and proximal femur BMDs were similar to 1 SD lower in men and women taking OG or high-dose IG for chronic bronchial asthma, potentially equivalent to a doubling of the risk of fracture at these sites. Prior exposure to OG in women was also associated with lower LS and proximal femur BMDs, while men were more sensitive to the adverse effects of IG on LS and Ward's triangle BMDs, Bone formation markers were decreased; however, bone resorption marker concentrations were normal. All patients had evidence of suppression of both endogenous glucocorticoid and adrenal androgen production. Both total duration of OG and biochemical bone turnover marker concentrations were negatively related to proximal femur and rib BMDs and total body bone mineral content, but not to LS BMD, These were stronger for bone resorption markers. Uncoupling of ongoing normal bone resorption from suppressed bone formation may therefore contribute to glucocorticoid-associated bone loss in asthma, Adrenal androgen suppression may also increase the susceptibility of postmenopausal women in particular to bone loss with OG, Although the effects of high-dose IG on BMD are associated with lower LS BMD in men, this observation should now be investigated further in prospective studies.
引用
收藏
页码:1283 / 1289
页数:7
相关论文
共 50 条
  • [21] Bone mineral density and bone histomorphometry in children on long-term dialysis
    Maria Cristina Andrade
    João Tomás Carvalhaes
    Aluizio Barbosa Carvalho
    Marise Lazarretti-Castro
    Cynthia Brandão
    Pediatric Nephrology, 2007, 22 : 1767 - 1772
  • [22] Enterocystoplasty: The long-term effects on bone mineral density
    Hensle, Terry W.
    Reiley, Elizabeth A.
    Fam, Mina M.
    Carpenter, Christina P.
    JOURNAL OF PEDIATRIC UROLOGY, 2016, 12 (04) : 245.e1 - 245.e6
  • [23] LONG-TERM ADMINISTRATION OF FENSPIRIDE HAS NO NEGATIVE IMPACT ON BONE MINERAL DENSITY AND BONE TURNOVER IN YOUNG GROWING RATS
    Matuszewska, A.
    Nowak, B.
    Jedrzejuk, D.
    Landwojtowicz, M.
    Bolanowski, M.
    Dziewiszek, W.
    Szelag, E.
    Zduniak, K.
    Kwiatkowska, J.
    Szelag, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1112 - 1112
  • [24] Bone mineral density and glucocorticoids
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2022, 4 (08): : E531 - E531
  • [25] Bone mineral density and bone turnover markers in patients on long-term suppressive levothyroxine therapy for differentiated thyroid cancer
    Lee, Mi Young
    Park, Jae Hyun
    Bae, Keum Seok
    Jee, Yong Gwan
    Ko, An Na
    Han, Yong Jea
    Shin, Jang Yel
    Lim, Jung Soo
    Chung, Choon Hee
    Kang, Seong Joon
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2014, 86 (02) : 55 - 60
  • [26] Long-term administration of fenspiride has no negative impact on bone mineral density and bone turnover in young growing rats
    Matuszewska, Agnieszka
    Nowak, Beata
    Jedrzejuk, Diana
    Landwojtowicz, Marcin
    Bolanowski, Marek
    Dziewiszek, Wojciech
    Merwid-Lad, Anna
    Szelag, Ewa
    Zduniak, Krzysztof
    Kwiatkowska, Joanna
    Szelag, Adam
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 28 (06): : 771 - 776
  • [27] Long-term effects of denosumab on bone mineral density and turnover markers in patients undergoing hemodialysis
    Kato, Kazuhiko
    Yaginuma, Tatsuhiro
    Kobayashi, Arisa
    Nakashima, Akio
    Ohkido, Ichiro
    Yokoo, Takashi
    JOURNAL OF BONE AND MINERAL METABOLISM, 2024, 42 (02) : 264 - 270
  • [28] Long-term effects of denosumab on bone mineral density and turnover markers in patients undergoing hemodialysis
    Kazuhiko Kato
    Tatsuhiro Yaginuma
    Arisa Kobayashi
    Akio Nakashima
    Ichiro Ohkido
    Takashi Yokoo
    Journal of Bone and Mineral Metabolism, 2024, 42 : 264 - 270
  • [29] Long term effect of inhaled corticosteroids on bone mineral density in patients with asthma
    Wong, CA
    Walsh, LJ
    Smith, C
    Wisniewski, AF
    Lewis, SA
    Hubbard, R
    Green, DJ
    Pringle, M
    Tattersfield, AE
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A918 - A918
  • [30] Does long-term oral anticoagulant therapy impair bone mineral density in children?
    Avgeri, M.
    Platokouki, H.
    Paladoloulou, A.
    Douros, K.
    Rammos, S.
    Nicolaidou, P.
    Aronis, S.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (03) : 382 - 382